Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCV (Genotype 1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00561353
What this trial is testing

TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec Pharmaceuticals, Ireland 121
Large-scale testing (Phase 3)WithdrawnNCT01608737
What this trial is testing

A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT00781274
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 32
Large-scale testing (Phase 3)Ended earlyNCT00662220
What this trial is testing

High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 110
Large-scale testing (Phase 3)Study completedNCT00780910
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 109
Large-scale testing (Phase 3)WithdrawnNCT01890772
What this trial is testing

Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1

Who this might be right for
Hepatitis C
Timothy Morgan, MD
Large-scale testing (Phase 3)Study completedNCT01433887
What this trial is testing

Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 535
Large-scale testing (Phase 3)Study completedNCT02442284
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis CCirrhosisHepatitis C Virus
AbbVie 99
Post-approval studies (Phase 4)UnknownNCT04997564
What this trial is testing

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
Peking University First Hospital 120
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Not applicableStudy completedNCT02669940
What this trial is testing

Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

Who this might be right for
Chronic Hepatitis CGenotype 1
AbbVie 158
Large-scale testing (Phase 3)Study completedNCT01728324
What this trial is testing

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 496
Large-scale testing (Phase 3)Study completedNCT01716585
What this trial is testing

Evaluate Chronic Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 636
Large-scale testing (Phase 3)Study completedNCT01715415
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 395
Large-scale testing (Phase 3)Study completedNCT01725529
What this trial is testing

An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 457
Testing effectiveness (Phase 2)Study completedNCT01012895
What this trial is testing

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 215
Testing effectiveness (Phase 2)Study completedNCT00336479
What this trial is testing

Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 263
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Study completedNCT02167945
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 615
Testing effectiveness (Phase 2)Study completedNCT01194037
What this trial is testing

A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

Who this might be right for
Chronic Hepatitis C InfectionGenotype 1
HanAll BioPharma Co., Ltd. 30
Next Page